Preambolo 1
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC ( 1 ) , and in particular Article 20(1) and Article 78(2) thereof,
Whereas:
HAS ADOPTED THIS REGULATION:
recital 1recital 1
(1) Commission Directive 2006/16/EC ( 2 ) included oxamyl as an active substance in Annex I to Council Directive 91/414/EEC ( 3 ) .
recital 2recital 2
(2) Active substances included in Annex I to Directive 91/414/EEC are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 ( 4 ) .
recital 3recital 3
(3) The approval of the active substance oxamyl, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 31 October 2023.
recital 4recital 4
(4) An application for the renewal of the approval of the active substance oxamyl was submitted to Italy, the rapporteur Member State, and France, the co-rapporteur Member State, in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 ( 5 ) within the time period provided for in that Article.
recital 5recital 5
(5) The applicant submitted the supplementary dossiers to the rapporteur Member State, the co-rapporteur Member State, the Commission and the European Food Safety Authority (‘the Authority’) in accordance with Article 6 of Implementing Regulation (EU) No 844/2012. The application was found to be complete by the rapporteur Member State.
recital 6recital 6
(6) The rapporteur Member State prepared a draft renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the Authority and the Commission on 15 October 2019.
recital 7recital 7
(7) The Authority made the supplementary summary dossier available to the public. The Authority also circulated the draft renewal assessment report to the applicant and to the Member States for comments and launched a public consultation on it. The Authority forwarded the comments received to the Commission.
recital 8recital 8
(8) On 30 March 2022, the Authority communicated to the Commission its conclusion ( 6 ) on whether oxamyl can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
recital 9recital 9
(9) In its conclusion, the Authority identified a number of concerns. In particular, it concluded that there is a high risk for all the representative uses assessed to exceed the acceptable operator exposure level (‘AOEL’) for operators even with the use of personal protective equipment (‘PPE’).
recital 10recital 10
(10) Furthermore, the preliminary acute consumer dietary risk assessment indicated a large exceedance of the acute reference dose (‘ARfD‘) for all the representative uses on all edible crops. In addition, the consumer risk assessment through drinking water indicated that the theoretical maximum daily intake (‘TMDI’) from the groundwater metabolite IN-D2708 exceeded the acceptable daily intake (‘ADI’) for adults, children and infants in all representative uses and that the TMDI from the groundwater metabolite IN-A2213 exceeded the ADI for infants in all representative uses.
recital 11recital 11
(11) The Commission presented a renewal report concerning the approval of oxamyl as well as a draft of this Regulation to the Standing Committee on Plants, Animals, Food and Feed on 13 October 2022 and 8 December 2022 respectively.
recital 12recital 12
(12) The Commission invited the applicant to submit its comments on the conclusion of the Authority. Furthermore, in accordance with Article 14(1), third subparagraph, of Implementing Regulation (EU) No 844/2012, the Commission invited the applicant to submit comments on the renewal report.
recital 13recital 13
(13) Despite the arguments put forward by the applicant, the concerns regarding the active substance could not be eliminated.
recital 14recital 14
(14) Consequently, it has not been established, with respect to one or more representative uses of at least one plant protection product, that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied. It is therefore appropriate not to renew the approval of the active substance oxamyl.
recital 15recital 15
(15) Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
recital 16recital 16
(16) Member States should be given sufficient time to withdraw authorisations for plant protection products containing oxamyl.
recital 17recital 17
(17) For plant protection products containing oxamyl, where Member States grant any grace period in accordance with Article 46 of Regulation (EC) No 1107/2009, that period should at the latest, expire on 30 September 2023.
recital 18recital 18
(18) Commission Implementing Regulation (EU) 2023/116 ( 7 ) extends the approval period of oxamyl to 31 October 2023 in order to allow the renewal process to be completed before the expiry of the approval period. However, given that a decision on the non-renewal of the approval has been taken ahead of that extended expiry date, this Regulation should apply earlier than that date.
recital 19recital 19
(19) This Regulation does not prevent the submission of a further application for the approval of oxamyl pursuant to Article 7 of Regulation (EC) No 1107/2009.
recital 20recital 20
(20) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
Articolo 1Non-renewal of the approval of the active substance
The approval of the active substance oxamyl is not renewed.
Articolo 2Amendment to Implementing Regulation (EU) No 540/2011
In Part A of the Annex to Implementing Regulation (EU) No 540/2011, row 116 on oxamyl is deleted.
Articolo 3Transitional measures
Member States shall withdraw authorisations for plant protection products containing oxamyl as an active substance by 1 August 2023.
Articolo 4Grace period
Any grace period granted by Member States in accordance with Article 46 of Regulation (EC) No 1107/2009 shall expire by 1 November 2023.
Articolo 5Entry into force
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .